These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2790786)

  • 21. Epidermal growth factor differentially regulates low density lipoprotein receptor-related protein gene expression in neoplastic and fetal human astrocytes.
    Hussaini IM; Brown MD; Karns LR; Carpenter J; Redpath GT; Gonias SL; Vandenberg SR
    Glia; 1999 Jan; 25(1):71-84. PubMed ID: 9888299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of epidermal growth factor receptor activity and related responses by the 7-deazaguanine derivative, queuine.
    Langgut W; Reisser T; Kersten H; Nishimura S
    Oncogene; 1993 Nov; 8(11):3141-7. PubMed ID: 8414516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the epidermal growth factor receptor associated with cytoskeletons of A431 cells.
    Roy LM; Gittinger CK; Landreth GE
    J Cell Physiol; 1989 Aug; 140(2):295-304. PubMed ID: 2745564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of cytotoxic effect of epidermal growth factor (EGF) on EGF receptor overexpressing cells is associated with attenuation of EGF receptor tyrosine kinase activity.
    Gardner DP; Shimizu N
    J Cell Physiol; 1994 Feb; 158(2):245-55. PubMed ID: 8106561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased expression of the epidermal growth factor receptor in human epidermal keratinocytes after exposure to ionizing radiation.
    Peter RU; Beetz A; Ried C; Michel G; van Beuningen D; Ruzicka T
    Radiat Res; 1993 Oct; 136(1):65-70. PubMed ID: 8210340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene modulation accompanying differentiation of normal versus malignant keratinocytes.
    Yaar M; Gilani A; DiBenedetto PJ; Harkness DD; Gilchrest BA
    Exp Cell Res; 1993 Jun; 206(2):235-43. PubMed ID: 8500546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidermal growth factor induces terminal differentiation in human epidermoid carcinoma cells.
    Konger RL; Chan TC
    J Cell Physiol; 1993 Sep; 156(3):515-21. PubMed ID: 8103053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of epidermal growth factor on transferrin receptor phosphorylation and surface expression in malignant epithelial cells.
    Castagnola J; MacLeod C; Sunada H; Mendelsohn J; Taetle R
    J Cell Physiol; 1987 Sep; 132(3):492-500. PubMed ID: 3498729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple responses to EGF receptor activation and their abrogation by a specific EGF receptor tyrosine kinase inhibitor.
    Harper ME; Goddard L; Glynne-Jones E; Assender J; Dutkowski CM; Barrow D; Dewhurst OL; Wakeling AE; Nicholson RI
    Prostate; 2002 Jun; 52(1):59-68. PubMed ID: 11992620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transforming growth factor-alpha production and autoinduction in a colorectal carcinoma cell line (DiFi) with an amplified epidermal growth factor receptor gene.
    Untawale S; Zorbas MA; Hodgson CP; Coffey RJ; Gallick GE; North SM; Wildrick DM; Olive M; Blick M; Yeoman LC
    Cancer Res; 1993 Apr; 53(7):1630-6. PubMed ID: 8453634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2.
    Ram TG; Dilts CA; Dziubinski ML; Pierce LJ; Ethier SP
    Mol Carcinog; 1996 Mar; 15(3):227-38. PubMed ID: 8597535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potent SHC tyrosine phosphorylation by epidermal growth factor at low receptor density or in the absence of receptor autophosphorylation sites.
    Soler C; Alvarez CV; Beguinot L; Carpenter G
    Oncogene; 1994 Aug; 9(8):2207-15. PubMed ID: 8036006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autocrine transforming growth factor alpha is dispensible for v-rasHa-induced epidermal neoplasia: potential involvement of alternate epidermal growth factor receptor ligands.
    Dlugosz AA; Cheng C; Williams EK; Darwiche N; Dempsey PJ; Mann B; Dunn AR; Coffey RJ; Yuspa SH
    Cancer Res; 1995 May; 55(9):1883-93. PubMed ID: 7728756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increase in epidermal growth factor receptor and its mRNA levels by parathyroid hormone (1-34) and parathyroid hormone-related protein (1-34) during differentiation of human trophoblast cells in culture.
    Alsat E; Haziza J; Scippo ML; Frankenne F; Evain-Brion D
    J Cell Biochem; 1993 Sep; 53(1):32-42. PubMed ID: 8227181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways.
    Tuck AB; Hota C; Wilson SM; Chambers AF
    Oncogene; 2003 Feb; 22(8):1198-205. PubMed ID: 12606946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.
    Liu J; Spence MJ; Wallace PM; Forcier K; Hellström I; Vestal RE
    Cell Growth Differ; 1997 Jun; 8(6):667-76. PubMed ID: 9186000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidermal growth factor receptor in cultured human retinal pigment epithelial cells.
    Yan F; Hui YN; Li YJ; Guo CM; Meng H
    Ophthalmologica; 2007; 221(4):244-50. PubMed ID: 17579290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of estrogen receptors in estrogen receptor-negative human breast carcinoma cells: modulation of epidermal growth factor-receptor (EGF-R) and transforming growth factor alpha (TGF alpha) gene expression.
    Sheikh MS; Shao ZM; Chen JC; Li XS; Hussain A; Fontana JA
    J Cell Biochem; 1994 Mar; 54(3):289-98. PubMed ID: 8200909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tyrosine kinase inhibitors. 13. Structure-activity relationships for soluble 7-substituted 4-[(3-bromophenyl)amino]pyrido[4,3-d]pyrimidines designed as inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor.
    Thompson AM; Murray DK; Elliott WL; Fry DW; Nelson JA; Showalter HD; Roberts BJ; Vincent PW; Denny WA
    J Med Chem; 1997 Nov; 40(24):3915-25. PubMed ID: 9397172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of epidermal growth factor receptor activity by retinoic acid in glioma cells.
    Steck PA; Hadi A; Lotan R; Yung WK
    J Cell Biochem; 1990 Feb; 42(2):83-94. PubMed ID: 2307713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.